Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Avricore Health (AVCR) has expanded its patient testing with the HealthTab platform in select Shoppers Drug Mart pharmacies in BC
  • HealthTab is a turnkey point-of-care testing solution that screens for chronic diseases such as diabetes and heart disease
  • The agreement with Shoppers Drug Mart brings patients access to point-of-care blood screening and health-data management and has already seen success in Ontario
  • Avricore Health is a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at moving pharmacy forward
  • Shares in Avricore Health Inc. (AVCR) are steady, trading at $0.15 per share

Avricore Health (AVCR) has expanded its patient testing with the HealthTab platform in select Shoppers Drug Mart pharmacies in BC.

HealthTab is a turnkey point-of-care testing solution that screens for chronic diseases such as diabetes and heart disease. With just a few drops of blood from a finger prick, the system generates lab-accurate results on the spot and data is reported in real-time.

This expansion marks HealthTab’s debut in Western Canada and builds off the company’s agreement with Shoppers Drug Mart signed in May of this year.

With the point-of-care testing market expected to reach US$50.6 billion by 2025, Avricore’s HealthTab provides services to an increasingly broad audience.

Hector Bremner, Avricore Health’s CEO, commented on the expansion.

“The launch in Shoppers Drug Mart pharmacies in Ontario has been very successful and we are very happy to see the program lay the groundwork for expansion,” he said. “Having a real-time patient observation program reporting seamlessly across 3,000 kilometres is very unique and we are very proud to deliver this innovation.”

The agreement with Shoppers Drug Mart brings patients access to point-of-care blood screening and health-data management for potential risks associated with diabetes and cardiovascular conditions.

“Patient feedback, along with that of our pharmacists, has been very positive in Ontario with respect to HealthTab and we are evaluating how more patients can benefit from this type of service,” said Frank Hack, Director of Complex Care at Shoppers Drug Mart.

Avricore Health is a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at moving pharmacy forward.

Shares in Avricore Health Inc. (AVCR) are steady, trading at $0.15 per share as of 2:22 pm ET.

More From The Market Herald
Clearmind Medicine - CEO, Adi Zuloff Shani.

" Clearmind Medicine (CSE:CMND) announces upcoming pre-IND meeting with the FDA

Clearmind (CMND) will participate in a pre-IND meeting with the FDA on May 18, 2022.
The Market Herald Video

" ScreenPro Security (CSE:SCRN) acquires Naturevan Nutrition Ltd.

ScreenPro (SCRN) acquired all issued and outstanding shares of Naturevan for $2,200,000 in cash and ScreenPro shares.

" Entourage Health (TSXV:ENTG) announces proposed amendments to its issued and outstanding debentures

Entourage Health (ENTG) shareholders are being asked to vote in favour of proposed amendments to the trust indenture between TSX Trust and Entourage

" Aeterna Zentaris (TSX:AEZS) updates results from pre-clinical studies of its AIM Biologicals platform

Aeterna Zentaris (AEZS) has updated results from pre-clinical studies of its AIM Biologicals platform to treat Parkinson’s disease.